We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

78 hedge funds and large institutions have $339M invested in Regenxbio in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

69.11% more ownership

Funds ownership: 0% → 69.11% (+69%)

44% more capital invested

Capital invested by funds: $236M → $339M (+$103M)

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

10% more funds holding

Funds holding: 71 → 78 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
78
Holders Change
+7
Holders Change %
+9.86%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
31
Reduced
25
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.2M
2
BFA
BlackRock Fund Advisors
California
+$8.89M
3
BIT
BlackRock Institutional Trust
California
+$4.66M
4
PHS
PFM Health Sciences
California
+$4.04M
5
NCM
Numina Capital Management
New York
+$3.54M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$9.32M
2
VMI
VHCP Management II
New York
-$4.66M
3
SM
Sabby Management
Florida
-$4.1M
4
Axa
Axa
France
-$4.04M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$2.99M +$3.08M +161,208 New
AG
27
Artal Group
Luxembourg
$2.97M -$2.68M -140,000 -47%
CAM
28
Cormorant Asset Management
Massachusetts
$2.91M – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.86M +$1.87M +98,054 +175%
NIP
30
Nicholas Investment Partners
California
$1.83M +$1.89M +98,723 New
BIM
31
BlackRock Investment Management
Delaware
$1.56M +$4.68K +245 +0.3%
Citadel Advisors
32
Citadel Advisors
Florida
$1.43M +$1.28M +67,167 +668%
Morgan Stanley
33
Morgan Stanley
New York
$1.35M +$933K +48,814 +202%
Charles Schwab
34
Charles Schwab
California
$1.29M +$73.6K +3,850 +6%
Deutsche Bank
35
Deutsche Bank
Germany
$1.17M +$460K +24,061 +62%
Russell Investments Group
36
Russell Investments Group
United Kingdom
$1.14M +$1.19M +62,141 New
TCIM
37
TIAA CREF Investment Management
New York
$1.11M -$7.7K -403 -0.7%
Ameriprise
38
Ameriprise
Minnesota
$1.03M +$1.07M +55,808 New
Bank of America
39
Bank of America
North Carolina
$942K -$75.6K -3,955 -7%
GAMA
40
Graticule Asia Macro Advisors
New York
$912K -$351K -18,350 -27%
SM
41
Sabby Management
Florida
$898K -$4.1M -214,777 -82%
Norges Bank
42
Norges Bank
Norway
$834K +$859K +44,943 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$832K +$857K +44,834 New
NFA
44
Nationwide Fund Advisors
Ohio
$792K +$571K +29,860 +233%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$775K -$19.1K -1,000 -2%
SSA
46
Schonfeld Strategic Advisors
New York
$742K +$764K +40,000 New
Victory Capital Management
47
Victory Capital Management
Texas
$666K -$248K -12,960 -27%
TA
48
Teachers Advisors
New York
$629K +$21.1K +1,102 +3%
CS
49
Credit Suisse
Switzerland
$616K +$634K +33,187 New
Swiss National Bank
50
Swiss National Bank
Switzerland
$605K +$623K +32,600 New
1
2
3 4

RGNX Hedge Fund Activity: Q4 2016 in Review

78 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2016, worth a combined $339M — up 44% from $236M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RGNX positions and 10 closed out — a net gain of 8 holders — while 31 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $27.2M. The largest seller was Vivo Capital, cutting an estimated $9.32M.

  • 78 institutional investors held Regenxbio (RGNX) as of Q4 2016, up from 71 in Q3 2016.
  • Funds reported $339M of Regenxbio stock for Q4 2016, up 44% quarter-over-quarter.
  • 18 funds opened new Regenxbio positions in Q4 2016 and 10 closed out, a net change of +8 holders.
  • The largest Regenxbio buyer in Q4 2016 was Fidelity Investments, an estimated $27.2M added.
  • The largest Regenxbio seller in Q4 2016 was Vivo Capital, an estimated $9.32M sold.

Based on aggregated 13F filings for Q4 2016.